News & Updates

Show Multimedia Only
Continued anti-VEGF use after disease control does not prevent nAMD recurrence

Continued anti-VEGF use after disease control does not prevent nAMD recurrence

06 Apr 2022

In patients with neovascular age-related macular degeneration (nAMD) who achieve functional and morphological disease stability, continuing treatment with antivascular endothelial growth factors (anti-VEGF) does not substantially reduce the risk of recurrence, reports a recent study.

06 Apr 2022
Insulin pump, CGM use linked to better glucose control during pregnancy

Insulin pump, CGM use linked to better glucose control during pregnancy

06 Apr 2022

The use of either an insulin pump or a continuous glucose monitoring (CGM) device among pregnant women with type 1 diabetes leads to improved glycaemic control, although pump use appears to be linked to higher birth weight measures, a study has found.

06 Apr 2022